GEODE CAPITAL MANAGEMENT, LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,373,765
+27.1%
534,503
-5.5%
0.00%
Q2 2023$1,867,169
-38.3%
565,809
-46.8%
0.00%
Q1 2023$3,028,506
+48511.7%
1,062,634
+24.2%
0.00%
-100.0%
Q4 2022$6,230
-99.9%
855,832
+36.9%
0.00%0.0%
Q3 2022$5,056,000
+82.2%
625,070
+10.3%
0.00%
Q2 2022$2,775,000
-77.9%
566,513
+6.9%
0.00%
-100.0%
Q1 2022$12,537,000
+42.3%
530,137
+6.5%
0.00%
+100.0%
Q4 2021$8,809,000
-31.9%
498,005
+8.6%
0.00%
-50.0%
Q3 2021$12,932,000
+246.1%
458,442
+28.6%
0.00%
+100.0%
Q2 2021$3,737,000
+11.4%
356,592
+25.2%
0.00%0.0%
Q1 2021$3,354,000
+38.0%
284,737
+37.1%
0.00%
Q4 2020$2,431,000
+107.1%
207,670
+40.2%
0.00%
Q3 2020$1,174,000
-49.1%
148,083
+17.4%
0.00%
Q2 2020$2,306,000
+60.5%
126,122
+4.8%
0.00%
Q1 2020$1,437,000
-26.4%
120,402
+2.6%
0.00%
Q4 2019$1,952,000
+960.9%
117,402
+322.4%
0.00%
Q3 2019$184,00027,7910.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders